Fresh filings show a sharp split in insider sentiment across US stocks.
Corvex Management made the boldest recent bet. The asset manager bought over $28M worth of WGS (GeneDx Holdings) shares across three days last week. All trades were filed Monday. GeneDx is a genomic testing company. The cluster of buying — from a board-represented fund — signals strong conviction in the stock.
ALKT (Alkami Technology) drew similar attention. General Atlantic, a private equity firm on its board, poured $34.7M into the fintech over three days in early May. Shares were bought at prices ranging from $16.63 to $16.92.
On the buying side for executives, UPST founder and Chairman Dave Girouard filed a $5M personal purchase on May 8. He bought 169,940 shares at roughly $29.37 each. Founders buying their own stock with personal funds is a strong bullish signal.
Not everyone is optimistic. TWLO (Twilio) saw a board-connected hedge fund sell $130.6M worth of shares on May 12 — filed the same day. HWM (Howmet Aerospace) also saw its Chief Administration Officer sell $11.3M worth of stock on May 11. CFO William George sold $7.8M in Comfort Systems USA shares on May 8.
This article is for informational purposes only and does not constitute financial advice.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
